InsiderDB

Lobbying disclosures · Lobbying report

ABBV: third_quarter 2026 lobbying report

A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.

Follow ABBV
Became public
Oct 19, 2026, 1:58 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 9:38 AM EST

Why this is connected

Exact legal-name match: AbbVie Inc. (https://www.sec.gov/Archives/edgar/data/1551152/).

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/06f06a4d-3a89-4cdc-9314-b4e20eb8939a/","filing_uuid":"06f06a4d-3a89-4cdc-9314-b4e20eb8939a","filing_type":"Q3Y","filing_type_display":"3rd Quarter - Report (No Activity)","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/06f06a4d-3a89-4cdc-9314-b4e20eb8939a/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Chris Jones","dt_posted":"2026-10-19T13:58:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1050 Connecticut Avenue, N.W.","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":5131,"url":"https://lda.gov/api/v1/registrants/5131/","house_registrant_id":30019,"name":"BAKER & HOSTETLER LLP","description":"Law firm","address_1":"1050 Connecticut Ave NW Suite 1100","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRIS JONES","contact_telephone":"+1 202-861-1500","dt_updated":"2026-07-31T17:01:51.150975-04:00"},"client":{"id":105314,"url":"https://lda.gov/api/v1/clients/105314/","client_id":3045,"name":"ABBVIE, INC.","general_description":"Pharmaceutical researcher and manufacturer","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-03-01"},"lobbying_activities":[],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+0.37% ABBV

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in ABBV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.